ASMANEX is a Respiratory (inhalation) Inhalant in the Human Prescription Drug category. It is labeled and distributed by Merck Sharp & Dohme Corp.. The primary component is Mometasone Furoate.
Product ID | 0085-1341_22ce7e61-648f-4680-b024-f35096bf5d82 |
NDC | 0085-1341 |
Product Type | Human Prescription Drug |
Proprietary Name | ASMANEX |
Generic Name | Mometasone Furoate |
Dosage Form | Inhalant |
Route of Administration | RESPIRATORY (INHALATION) |
Marketing Start Date | 2005-03-30 |
Marketing Category | NDA / NDA |
Application Number | NDA021067 |
Labeler Name | Merck Sharp & Dohme Corp. |
Substance Name | MOMETASONE FUROATE |
Active Ingredient Strength | 220 ug/1 |
Pharm Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Corticosteroid Hormone Receptor Agonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2005-03-30 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021067 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2005-03-30 |
Marketing Category | NDA |
Application Number | NDA021067 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2005-03-30 |
Marketing Category | NDA |
Application Number | NDA021067 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2005-03-30 |
Marketing Category | NDA |
Application Number | NDA021067 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2005-03-30 |
Marketing End Date | 2014-10-07 |
Marketing Category | NDA |
Application Number | NDA021067 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2005-03-30 |
Marketing End Date | 2015-01-31 |
Marketing Category | NDA |
Application Number | NDA021067 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2005-03-30 |
Marketing Category | NDA |
Application Number | NDA021067 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2005-03-30 |
Ingredient | Strength |
---|---|
MOMETASONE FUROATE | 220 ug/1 |
SPL SET ID: | 1ec2b62b-6bf5-4d70-8824-9d90e2d87a68 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0085-1341 | ASMANEX | Mometasone Furoate |
0085-1461 | ASMANEX | Mometasone Furoate |
0085-2222 | ASMANEX HFA | MOMETASONE FUROATE |
0085-4333 | ASMANEX HFA | MOMETASONE FUROATE |
0085-4334 | ASMANEX HFA | MOMETASONE FUROATE |
0085-0370 | ELOCON | mometasone furoate |
0085-0854 | ELOCON | Mometasone Furoate |
0085-3149 | ELOCON | Mometasone Furoate |
0168-0270 | Mometasone Furoate | mometasone furoate |
0168-0271 | Mometasone Furoate | mometasone furoate |
0168-0272 | Mometasone Furoate | mometasone furoate |
0713-0634 | Mometasone Furoate | Mometasone Furoate |
0113-1720 | Nasonex | mometasone furoate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ASMANEX 78489101 3127884 Dead/Cancelled |
MERCK SHARP & DOHME CORP. 2004-09-24 |
ASMANEX 76029251 not registered Dead/Abandoned |
SCHERING CORPORATION 2000-04-18 |
ASMANEX 74462173 2136067 Live/Registered |
MERCK SHARP & DOHME CORP. 1993-11-22 |